Current Report · Items 5.02 · 8-K
Astrana Health Inc.
ASTHNASDAQEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 25, 2026, Glenn Sobotka, the Chief Accounting Officer and principal accounting officer of Astrana Health, Inc. (the “Company”), and the Company agreed that Mr. Sobotka will retire from his positions with the Company effective as of August 7, 2026. Mr.…
Filed Jul 1, 2026Accepted Jul 1, 2026, 4:15 PM EDTCIK 1083446Accession 0001104659-26-079874
Company context
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system.
Current securities
Disclosure sections
Items 5.02Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On June 25, 2026, Glenn Sobotka, the Chief Accounting Officer and principal
accounting officer of Astrana Health, Inc. (the “Company”), and the Company agreed that Mr. Sobotka will retire from his positions
with the Company effective as of August 7, 2026. Mr. Sobotka’s retirement is not the result of any disagreement with the Company
on any matter relating to the Company’s operations, policies, or practices.
John Vong, who has been appointed as Senior Vice President -
Accounting effective July 1, 2026, will succeed Mr. Sobotka as the Company’s principal accounting officer, effective as of August
7, 2026. Mr. Vong, 52, has previously served as the Company’s Group Vice President, Accounting since March 2025. Prior to that,
Mr. Vong served as the Company’s Chief Accounting Officer and principal accounting officer from November 2022 to March 2025 and
as its Vice President of Finance and Accounting from July 2022 to November 2022. Prior to joining the Company, Mr. Vong served as Vice
President of Finance and Accounting at Prospect Medical Systems, Inc. from February 2016 to July 2022. Mr. Vong began his career as a
certified public accountant with RSM. Mr. Vong received a Bachelor of Science degree in Business Administration from the University of
California, Riverside and a Master of Business Administration degree from the University of California, Irvine.
Effective as of July 1, 2026, Mr. Vong’s annual base salary will
increase to $320,000. Mr. Vong’s target bonus opportunity as a percentage of his annual base salary for 2026 pursuant to his employee
agreement remains unchanged.
There is no arrangement or understanding between Mr. Vong or any other
person pursuant to which he was selected as principal accounting officer of the Company, and there are no family relationships between
Mr. Vong and any of the Company’s directors or executive officers. There are no transactions to which the Company is a party and
in which Mr. Vong has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K.